Portfolio Management: Oversaw the bioprocess, cell culture, and microbiology equipment portfolio, including bioreactors and filtration systems, specifically for the Middle Eastern market.Client Relations: Developed and sustained robust relationships with key clients and industry stakeholders, ensuring high levels of satisfaction and loyalty.Technical Support & Training: Delivered expert technical support, troubleshooting, and comprehensive product training to customers, enhancing their operational efficiency and product utilization.Market Insight & Product Development: Partnered with internal teams to analyze market trends and drive the development of innovative products and services tailored to emerging industry needs.

- Led the development and validation of cell-based bioassays, immunoassays, and bioanalytical methods to ensure accuracy and reliability in testing.- Reviewed technical dossiers to evaluate the feasibility of technology transfers, facilitating the introduction of new products with optimized processes.- Conducted stability studies and characterization of biosimilars, ensuring their quality and performance over time.- Conducted biotech process development and optimization, focusing on the production and enhancement of insulin, glargine, and erythropoietin to improve yields and efficiency.- Developed and validated quality attribute methods for vaccines, enhancing analytical precision and product safety.- Managed DNA extraction and quantification of high-concentration DNA and proteins, ensuring robust and reproducible results.- Provided training and development for team members, fostering expertise in analytical techniques and regulatory compliance.- Oversaw analytical method transfers and conducted impurity depletion studies to ensure accurate method implementation and effective impurity management.- Conducted equipment qualifications, troubleshot technical issues, and maintained operational efficiency.- Handled change controls, deviations, and CAPAs to uphold quality standards and address any non-conformances.- Investigated out-of-specification (OOS) and out-of-trend (OOT) results to identify root causes and implement corrective actions.-Managed inventory to ensure the availability of necessary materials and reagents for ongoing research and development activities.

Managed cell lines, cell banking, culture, and characterization to support drug discovery and development processes.Executed sample preparation, PCR, RT-PCR, and high-throughput screening with liquid handling systems.Designed primers, conducted sequencing (NGS), and performed data analysis, restriction enzyme digestion, ligation, transient transfection, and stable cell generation.Developed and validated cell-based bioassays using various platforms, including ELISA, HTRF, AlphaScreen, and Meso Scale Discovery (electrochemiluminescence).Created novel methodologies to identify the mode of action (MOA) for new chemical entities (NCEs).Conducted ex vivo assays, including rat islet isolation and insulin and glucagon secretion assay development and validation.

Primary Cell Isolations & Culture: Expertise in isolating and culturing primary cells, including stem cells, neutrophils, PBMCs, aortic endothelial cells, keratinocytes, and melanocytes, along with managing cell banking procedures.Cell Line Characterization: Conducted detailed characterization of primary cell lines, including defining passage numbers to ensure consistency and reliability in experimental results.3D Skin Development: Developed and optimized 3D skin models for research and testing applications, advancing in vitro skin research and product development.Bioprocess Experience: Led cell line development and optimization processes for the production of recombinant therapeutic proteins, enhancing yields and process efficiency.

• Plasmid isolation, Primer design, RE digestion, Ligation, transformation & Agarose Gel electrophoresis • Development of ADCC & CDC assays by NK cell and PBMC cells• PK/PD Studies• Histopathology (Microtome sectioning & Staining)• Cloning